• Home
  •  / Advanced Cell Diagnostics

Advanced Cell Diagnostics

OverviewSuggest Edit

ACD shortens the path to personalized medicine by unlocking the power of RNA biomarkers. Advanced Cell Diagnostics, Inc. (ACD) is a leader in the emerging field of molecular pathology, developing cell- and tissue-based diagnostic tests for personalized medicine. Based in the heart of Silicon Valley, ACD was founded and managed by experienced entrepreneurs in the life science industry. ACD’s products and services are based on its proprietary RNAscope® technology, the first multiplex fluorescent and chromogenic in situ hybridization platform capable of detecting and quantifying RNA biomarkers in situ at single molecule sensitivity.
TypePrivate
Founded2006
HQNewark, CA, USMap
Websiteacdbio.com
View Jobs

Recent NewsAll News

Latest Updates

Employees (est.) (Apr 2021)146(+3%)

Key People/Management at Advanced Cell Diagnostics

Xiao-Jun Ma

Xiao-Jun Ma

Chief Scientific Officer
Rob Monroe

Rob Monroe

Chief Medical Officer
Jessie Qian Wang

Jessie Qian Wang

Chief Financial Officer
Christopher Bunker

Christopher Bunker

VP, Business Development
Show more

Advanced Cell Diagnostics Office Locations

Advanced Cell Diagnostics has offices in Newark, Hayward and Malpaga
Newark, CA, US (HQ)
7707 Gateway Blvd
Hayward, CA, US
3960 Point Eden Way
Malpaga, IT
Via Toscana, 2
Show all (4)

Advanced Cell Diagnostics Financials and Metrics

Summary Metrics

Founding Date

2006

Advanced Cell Diagnostics total Funding

$39.4 m

Advanced Cell Diagnostics latest funding size

$22 m

Time since last funding

6 years ago

Advanced Cell Diagnostics investors

Summit Partners, New Leaf Venture Partners, Morningside Group, Kenson Ventures, Morningside Ventures
Advanced Cell Diagnostics's latest funding round in June 2015 was reported to be $22 m. In total, Advanced Cell Diagnostics has raised $39.4 m
Show all financial metrics

Advanced Cell Diagnostics Online and Social Media Presence

Advanced Cell Diagnostics's Trends

Embed Graph

Advanced Cell Diagnostics News and Updates

October 30, 2018

Circulating Tumor Cell Diagnostics Global Market 2018 Top Key Players – Janssen Diagnostics , Advanced Cell Diagnostics , Aviva Biosciences , Biocept Inc , Biofluidica Inc. , CellTraffix Inc. , Clearbridge BioMedics Pte Ltd and Forecast to 2023

Wiseguyreports.Com Added New Market Research Report On -“Circulating Tumor Cell Diagnostics Market 2018 Key Players, Applications and Future Demand Forecast to 2023 ”. Posted via Industry Today. Follow us on Twitter @IndustryToday
October 30, 2018

Circulating Tumor Cell Diagnostics Global Market 2018 Top Key Players – Janssen Diagnostics , Advanced Cell Diagnostics , Aviva Biosciences , Biocept Inc , Biofluidica Inc. , CellTraffix Inc. , Clearbridge BioMedics Pte Ltd and Forecast to 2023

Wiseguyreports.Com Added New Market Research Report On -“Circulating Tumor Cell Diagnostics Market 2018 Key Players, Applications and Future Demand Forecast to 2023 ”. Posted via Industry Today. Follow us on Twitter @IndustryToday
September 05, 2018

Cancer Stem Cells (CSCs) Market Size, Status and Forecast 2025: Leading Key players- Janssen, Qiagen, Advanced Cell Diagnostics, ApoCell

If you are involved in the Cancer Stem Cells industry or intend to be, then this study will provide you comprehensive outlook. Posted via Industry Today. Follow us on Twitter @IndustryToday

Advanced Cell Diagnostics Blogs

April 15, 2021

Cell & Gene Therapy Services

Application of RNAscope™ ISH in our Good Clinical Laboratory Practices (GCLP) compliant Professional Assay Services laboratory.  RNAscope is the only assay that can specifically detection engineered cell therapies and measure target engagement in intact human tumor biopsies.  Clinical trial cell …
March 31, 2021

RNAscope® HiPlex Probe - EGFP-sense-T4

RNAscope® HiPlex Probe - EGFP-sense-T4 - Cloning vector pEGFP-C1 complete sequencecttagtcaagcgt Add to compare
March 31, 2021

RNAscope® HiPlex Probe - EGFP-sense-T1

RNAscope® HiPlex Probe - EGFP-sense-T1 - Cloning vector pEGFP-C1 complete sequencecttagtcaagcgt Add to compare
March 31, 2021

RNAscope® HiPlex Probe - EGFP-sense-T2

RNAscope® HiPlex Probe - EGFP-sense-T2 - Cloning vector pEGFP-C1 complete sequencecttagtcaagcgt Add to compare
March 31, 2021

RNAscope® HiPlex Probe - EGFP-sense-T5

RNAscope® HiPlex Probe - EGFP-sense-T5 - Cloning vector pEGFP-C1 complete sequencecttagtcaagcgt Add to compare
March 31, 2021

RNAscope® HiPlex Probe - EGFP-sense-T3

RNAscope® HiPlex Probe - EGFP-sense-T3 - Cloning vector pEGFP-C1 complete sequencecttagtcaagcgt Add to compare
Show more

 Advanced Cell Diagnostics Frequently Asked Questions

  • When was Advanced Cell Diagnostics founded?

    Advanced Cell Diagnostics was founded in 2006.

  • Who are Advanced Cell Diagnostics key executives?

    Advanced Cell Diagnostics's key executives are Xiao-Jun Ma, Rob Monroe and Jessie Qian Wang.

  • How many employees does Advanced Cell Diagnostics have?

    Advanced Cell Diagnostics has 146 employees.

  • Who are Advanced Cell Diagnostics competitors?

    Competitors of Advanced Cell Diagnostics include Medexo, Healthians.com and Syapse.

  • Where is Advanced Cell Diagnostics headquarters?

    Advanced Cell Diagnostics headquarters is located at 7707 Gateway Blvd, Newark.

  • Where are Advanced Cell Diagnostics offices?

    Advanced Cell Diagnostics has offices in Newark, Hayward and Malpaga.

  • How many offices does Advanced Cell Diagnostics have?

    Advanced Cell Diagnostics has 4 offices.